Gene · 427
Papers1,873
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,873
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acid ceramidase ASAH1 is a key regulator of epidermal ceramide levels and composition. | J Biol Chem | 2026 | 41570988 | PubTator, text mining | PubMed |
| Association of programmed cell death with atrial fibrillation risk: A multi-omics Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41560081 | PubTator, text mining | PubMed |
| Anomaly-resilient geofencing and predictive navigation in IoT environments using machine learning and federated learning for metaverse workplaces and smart shopping malls. | Sci Rep | 2026 | 41554841 | PubTator, text mining | PubMed |
| A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy-Induced Cardiotoxicity. | Adv Sci (Weinh) | 2026 | 41545029 | PubTator, text mining | PubMed |
| Loss of Acid Ceramidase in Myeloid Cells Protects from Chronic Colitis in IL10-Deficent Mice. | bioRxiv | 2026 | 41542590 | PubTator, text mining | PubMed |
| ATP13A2-Mediated Spermine Export Modulates Lipid Catabolism in the Endolysosomal System of SH-SY5Y Cells. | Int J Mol Sci | 2026 | 41516358 | PubTator, text mining | PubMed |
| Roles of Acid Ceramidase and Its Cofactor in Biotherapeutics. | Mol Pharm | 2026 | 41364804 | PubTator, text mining | PubMed |
| Disrupting Lipid Raft Microdomains to Block Polyploid Giant Cancer Cell Budding and Enhance Radiotherapy Response. | Adv Sci (Weinh) | 2026 | 41330885 | PubTator, text mining | PubMed |
| Evaluation of Sphingolipid Metabolism in Silicosis Patients. | J Occup Environ Med | 2026 | 40788781 | PubTator, text mining | PubMed |
| An innovative machine learning-based QSAR approach for prediction and structural analysis of novel/repurposed acid ceramidase (ASAH1) inhibitors for glioblastoma therapy. | Mol Divers | 2026 | 40682750 | PubTator, text mining | PubMed |
| The Risk Genes S1PR5, CMC1, and ASAH1 as Potential Targets for the Diagnosis, Immunotherapy, and Treatment of Colon Adenocarcinoma by Single-Cell and Bulk RNA Sequencing Analysis. | Curr Med Chem | 2026 | 39513308 | PubTator, text mining | PubMed |
| Utility of Performing Routine Screening Tests of Infections in the Clinical Management of Preterm Labor in a Tertiary Hospital in the Philippines. | Acta Med Philipp | 2025 | 41536337 | PubTator, text mining | PubMed |
| Mosaic AAV mediates efficient transduction across the central and peripheral nervous systems. | Mol Brain | 2025 | 41457284 | PubTator, text mining | PubMed |
| Acid ceramidase regulates CD8+ T-cell exhaustion via type I interferon-mediated upregulation of PD-L1. | Front Immunol | 2025 | 41445750 | PubTator, text mining | PubMed |
| Acid ceramidase modulates the lipid profile and exacerbates sensitivity to ferroptosis in senescent cells. | Res Sq | 2025 | 41356368 | PubTator, text mining | PubMed |
| Acid ceramidase expression and biomarker potential in patients with locally advanced rectal cancer. | Biomol Biomed | 2025 | 41313810 | PubTator, text mining | PubMed |
| Proteome Landscapes Decode Organelle Vulnerabilities in cortical and dopaminergic-like induced neurons Across Lysosomal Storage Disorders. | bioRxiv | 2025 | 41279717 | PubTator, text mining | PubMed |
| ASAH1-mediated sphingolipid metabolic reprogramming in venetoclax resistance of AML: beyond the monocytic phenotypes. | BMC Cancer | 2025 | 41275169 | PubTator, text mining | PubMed |
| Characterization of Ceramide Kinase from Basolateral Membranes of Kidney Proximal Tubules: Kinetics, Physicochemical Requirements, and Physiological Relevance. | Int J Mol Sci | 2025 | 41226412 | PubTator, text mining | PubMed |
| Inhibition or genetic reduction of ASAH1/acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson's patients. | Hum Mol Genet | 2025 | 41224733 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/427/papers?page=3